Traditionally assessment of the effectiveness of cancer therapy relies on comparison of tumour images acquired before and after therapeutic intervention by inspection of cross-section images to evaluate changes in tumour size. Additionally, Diffusion weighted imaging (DWI) has proved to be a valuable tool in monitoring the effect of chemotherapy in clinical as well as in preclinical studies [1], especially early assessment of treatment induced changes using DWI seems to be a promising tool in the evaluation of novel therapies [2]. Ewing's sarcoma (ES) is the second most common bone tumor in children and adolescents. High dose chemotherapy followed by autologous stem cell rescue has been demonstrated to be associated with higher cure rates than conventional chemotherapy in relapsed patients. The goal of this Study was to evaluate diffusion-weighted magnetic resonance (MR) imaging for monitoring dose dependent tumour response in mouse-xenograft model of Ewing's Sarcoma after administration of Treosulfan in different dosages
Figure 1: Change of ADC during Therapy (Cellline, CHP-100)
